Login / Signup

Evaluation of Gabapentin as a Treatment of Breakthrough Cancer Pain Caused by Metastatic Prostate Adenocarcinoma.

Jufriady IsmyDessy R EmrilSaid Alfin KhalilullahMuhammad Puteh Mauny
Published in: Journal of pain research (2023)
The conclusion of this research is that gabapentin is effective in the treatment of BTcP caused by metastatic prostate adenocarcinoma.
Keyphrases
  • squamous cell carcinoma
  • prostate cancer
  • neuropathic pain
  • small cell lung cancer
  • benign prostatic hyperplasia
  • locally advanced
  • papillary thyroid
  • pain management
  • spinal cord injury
  • spinal cord